Oticon Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oticon Medical sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Oticon Medical: 7 sponsored US clinical trials, 2 recruiting.
Oticon Medical sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Unilateral, Profound Sensori-neural Hearing Loss, with 1 trials.
Upper-quartile sponsor footprint
Oticon Medical sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents
NCT06844071
Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-OR)
NCT06930781
Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures
NCT06421766
Pediatric Performance and Satisfaction of Oticon Medical Ponto on Softband.
NCT06638840
Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors
NCT05356221
Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)
NCT04279236
Wide Diameter Bone Anchored Implant Study
NCT01671176
What is open in the Oticon Medical pipeline
2 recruiting of 7 indexed (29% open); 5 completed (71%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Unilateral, Profound Sensori-neural Hearing Loss (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oticon Medical: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Oticon Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Oticon Medical page
7 registered trials is a research-attention snapshot, not an endorsement of Oticon Medical or any single study.
- 2 of Oticon Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Unilateral, Profound Sensori-neural Hearing Loss is the condition Oticon Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Unilateral, Profound Sensori-neural Hearing Loss trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Oticon Medical pipeline card: 7 registered trials from official public datasets.Report a data error.